ConductScience.org, home

Paper326072

Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine.

Clyde DF and 1 other. Am J Trop Med Hyg, 1977. Cited by 64 papers, by iCite.

Cite this record

ConductScience Library. Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine. Papers, record 326072. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/326072

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine.
PubMed
Journal
Am J Trop Med Hyg
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
2.38
iCite
Revised in PubMed
2022-03-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clyde DFD F
2McCarthy VCV C

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MalariaMajor topic
PrimaquineMajor topic
Adult
Clinical Trials as Topic
Drug Evaluation
Follow-Up Studies
Humans
Male
Plasmodium vivax
Recurrence
Time Factors

Source PubMed

Download CSV of topics

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
4011285214 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy study.Lancet Infect Dis2025https://conductscience.org/library/papers/40112852PubMed
31274189Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.Cochrane Database Syst Rev2019https://conductscience.org/library/papers/31274189PubMed
31031463Population pharmacokinetics of primaquine and the effect of hepatic and renal dysfunction: An exploratory approach.Indian J Pharmacol2019https://conductscience.org/library/papers/31031463PubMed
30952158Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.Clin Infect Dis2019https://conductscience.org/library/papers/30952158PubMed
29510711The ethics of using placebo in randomised controlled trials: a case study of a Plasmodium vivax antirelapse trial.BMC Med Ethics2018https://conductscience.org/library/papers/29510711PubMed
29317838Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname.Infect Drug Resist2018https://conductscience.org/library/papers/29317838PubMed
27708191Diagnosis and Treatment of Plasmodium vivax Malaria.Am J Trop Med Hyg2016https://conductscience.org/library/papers/27708191PubMed
26666941Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/26666941PubMed
24752682Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru.Am J Trop Med Hyg2014https://conductscience.org/library/papers/24752682PubMed
24189254Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24189254PubMed
24163057Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/24163057PubMed
22900786Primaquine radical cure of Plasmodium vivax: a critical review of the literature.Malar J2012https://conductscience.org/library/papers/22900786PubMed
22701198Failure of Supervised Chloroquine and Primaquine Regimen for the Treatment of Plasmodium vivax in the Peruvian Amazon.Malar Res Treat2012https://conductscience.org/library/papers/22701198PubMed
19597012Resistance to therapies for infection by Plasmodium vivax.Clin Microbiol Rev2009https://conductscience.org/library/papers/19597012PubMed
18165478Vivax malaria: neglected and not benign.Am J Trop Med Hyg2007https://conductscience.org/library/papers/18165478PubMed
17336652Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.Lancet2007https://conductscience.org/library/papers/17336652PubMed
15695723Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax.J Clin Microbiol2005https://conductscience.org/library/papers/15695723PubMed
11527798Plasmodium vivax polymorphism in a clinical drug trial.Clin Diagn Lab Immunol2001https://conductscience.org/library/papers/11527798PubMed
10488189Usefulness of seminested multiplex PCR in surveillance of imported malaria in Spain.J Clin Microbiol1999https://conductscience.org/library/papers/10488189PubMed
10461431Imported tertian malaria resistant to primaquine.Korean J Intern Med1999https://conductscience.org/library/papers/10461431PubMed

See all 24 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
G6PD2539PubTator's text mininghttps://conductscience.org/library/genes/2539

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/326072

GET https://conductscience.org/api/papers/v1/326072/cited_by?page=2